176 related articles for article (PubMed ID: 36889914)
1. High prevalence and incidence of gonorrhoea and chlamydia in young women eligible for HIV pre-exposure prophylaxis in South Africa and Zimbabwe: results from the HPTN 082 trial.
Delany-Moretlwe S; Mgodi N; Bekker LG; Baeten JM; Li C; Donnell D; Agyei Y; Lennon D; Rose SM; Mokgatle M; Kassim S; Mukaka S; Adeyeye A; Celum C
Sex Transm Infect; 2023 Nov; 99(7):433-439. PubMed ID: 36889914
[TBL] [Abstract][Full Text] [Related]
2. Alignment of PrEP adherence with periods of HIV risk among adolescent girls and young women in South Africa and Zimbabwe: a secondary analysis of the HPTN 082 randomised controlled trial.
Velloza J; Donnell D; Hosek S; Anderson PL; Chirenje ZM; Mgodi N; Bekker LG; Marzinke MA; Delany-Moretlwe S; Celum C
Lancet HIV; 2022 Oct; 9(10):e680-e689. PubMed ID: 36087612
[TBL] [Abstract][Full Text] [Related]
3. PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial.
Celum C; Hosek S; Tsholwana M; Kassim S; Mukaka S; Dye BJ; Pathak S; Mgodi N; Bekker LG; Donnell DJ; Wilson E; Yuha K; Anderson PL; Agyei Y; Noble H; Rose SM; Baeten JM; Fogel JM; Adeyeye A; Wiesner L; Rooney J; Delany-Moretlwe S
PLoS Med; 2021 Jun; 18(6):e1003670. PubMed ID: 34143779
[TBL] [Abstract][Full Text] [Related]
4. Sexually transmitted infection screening, prevalence and incidence among South African men and transgender women who have sex with men enrolled in a combination HIV prevention cohort study: the Sibanye Methods for Prevention Packages Programme (MP3) project.
Jones J; Sanchez TH; Dominguez K; Bekker LG; Phaswana-Mafuya N; Baral SD; McNaghten AD; Kgatitswe LB; Valencia R; Yah CS; Zahn R; Siegler AJ; Sullivan PS
J Int AIDS Soc; 2020 Oct; 23 Suppl 6(Suppl 6):e25594. PubMed ID: 33000886
[TBL] [Abstract][Full Text] [Related]
5. Trust in the provider and accurate self-reported PrEP adherence among adolescent girls and young women in South Africa and Zimbabwe: HPTN 082 study.
Beauchamp G; Donnell D; Hosek S; Anderson PL; Chan KCG; Dye BJ; Mgodi N; Bekker LG; Delany-Moretlwe S; Celum C
BMC Womens Health; 2023 May; 23(1):276. PubMed ID: 37208687
[TBL] [Abstract][Full Text] [Related]
6. Incidence and risk factors of C. trachomatis and N. gonorrhoeae among young women from the Western Cape, South Africa: The EVRI study.
Jongen VW; Schim van der Loeff MF; Botha MH; Sudenga SL; Abrahamsen ME; Giuliano AR
PLoS One; 2021; 16(5):e0250871. PubMed ID: 33939747
[TBL] [Abstract][Full Text] [Related]
7. Population-Level Correlation Between Incidence of Curable Sexually Transmitted Infections and Human Immunodeficiency Virus (HIV)-1 Among African Women Participating in HIV-1 Pre-Exposure Prophylaxis Trials.
Hunidzarira P; Brown ER; Chirenje ZM; Hillier SL; Marrazzo JM; Palanee-Phillips T; Kiweewa FM; Baeten JM;
J Infect Dis; 2022 Sep; 226(6):1069-1074. PubMed ID: 35763413
[TBL] [Abstract][Full Text] [Related]
8. High incidence of asymptomatic genital tract infections in pregnancy in adolescent girls and young women: need for repeat aetiological screening.
Govender V; Moodley D; Naidoo M; Connoly C; Ngcapu S; Abdool Karim Q
Sex Transm Infect; 2023 Nov; 99(7):482-488. PubMed ID: 37208192
[TBL] [Abstract][Full Text] [Related]
9. STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany.
Jansen K; Steffen G; Potthoff A; Schuppe AK; Beer D; Jessen H; Scholten S; Spornraft-Ragaller P; Bremer V; Tiemann C;
BMC Infect Dis; 2020 Feb; 20(1):110. PubMed ID: 32033533
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of Kenyan women using HIV PrEP enrolled in a randomized trial on doxycycline postexposure prophylaxis for sexually transmitted infection prevention.
Oware K; Adiema L; Rono B; Violette LR; McClelland RS; Donnell D; Scoville CW; Odoyo J; Baeten JM; Bukusi E; Stewart J
BMC Womens Health; 2023 Jun; 23(1):296. PubMed ID: 37270546
[TBL] [Abstract][Full Text] [Related]
11. Chlamydia trachomatis, Neisseria gonorrhoea, and Trichomonas vaginalis infections among pregnant women and male partners in Dutch midwifery practices: prevalence, risk factors, and perinatal outcomes.
Op de Coul ELM; Peek D; van Weert YWM; Morré SA; Rours I; Hukkelhoven C; de Jonge A; van Benthem B; Pereboom M
Reprod Health; 2021 Jun; 18(1):132. PubMed ID: 34174905
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, incidence and associated risk factors of STIs during pregnancy in South Africa.
Nyemba DC; Medina-Marino A; Peters RPH; Klausner JD; Ngwepe P; Myer L; Johnson LF; Davey DJ
Sex Transm Infect; 2021 Aug; 97(5):375-381. PubMed ID: 33004610
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of the Xpert CT/NG and OSOM Trichomonas Rapid assays for point-of-care STI testing among young women in South Africa: a cross-sectional study.
Garrett N; Mitchev N; Osman F; Naidoo J; Dorward J; Singh R; Ngobese H; Rompalo A; Mlisana K; Mindel A
BMJ Open; 2019 Feb; 9(2):e026888. PubMed ID: 30782948
[TBL] [Abstract][Full Text] [Related]
14. Incidence and Correlates of Sexually Transmitted Infections Among Black Men Who Have Sex With Men Participating in the HIV Prevention Trials Network 073 Preexposure Prophylaxis Study.
Hightow-Weidman LB; Magnus M; Beauchamp G; Hurt CB; Shoptaw S; Emel L; Piwowar-Manning E; Mayer KH; Nelson LE; Wilton L; Watkins P; Whitfield D; Fields SD; Wheeler D
Clin Infect Dis; 2019 Oct; 69(9):1597-1604. PubMed ID: 30615169
[TBL] [Abstract][Full Text] [Related]
15. PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project.
Celum CL; Bukusi EA; Bekker LG; Delany-Moretlwe S; Kidoguchi L; Omollo V; Rousseau E; Travill D; Morton JF; Mogaka F; O'Malley G; Barnabee G; van der Straten A; Donnell D; Parikh UM; Kudrick L; Anderson PL; Haberer JE; Wu L; Heffron R; Johnson R; Morrison S; Baeten JM;
J Int AIDS Soc; 2022 Jul; 25(7):e25962. PubMed ID: 35822945
[TBL] [Abstract][Full Text] [Related]
16. Point-of-care testing for sexually transmitted infections and HIV pre-exposure prophylaxis among pregnant women in South Africa, 2021-2022: randomised controlled trial.
de Voux A; Nyemba DC; Silliman M; Mashele N; Mvududu R; Myer L; Joseph Davey D
Sex Transm Infect; 2024 Feb; 100(2):77-83. PubMed ID: 38124133
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of asymptomatic sexually transmitted infections among human immunodeficiency virus-infected pregnant women in a low-income South African community.
Mudau M; Peters RP; De Vos L; Olivier DH; J Davey D; Mkwanazi ES; McIntyre JA; Klausner JD; Medina-Marino A
Int J STD AIDS; 2018 Mar; 29(4):324-333. PubMed ID: 28799824
[TBL] [Abstract][Full Text] [Related]
18. Comparing the Integration of Syndromic versus Etiological Management of Sexually Transmitted Infections Into HIV Pre-Exposure Prophylaxis Services for Adolescent Girls and Young Women, in South Africa.
Mullick S; Cox LA; Martin CE; Fipaza Z; Ncube S
J Adolesc Health; 2023 Dec; 73(6S):S67-S72. PubMed ID: 37953011
[TBL] [Abstract][Full Text] [Related]
19. Sexually Transmitted Infection Prevalence, Partner Notification, and Human Immunodeficiency Virus Risk Perception in a Cohort of Women Completing Sexually Transmitted Infection Screening as Part of a Safer Conception Study.
Beesham I; Isehunwa O; Kriel Y; Jaggernath M; Bennett K; Hurwitz K; Smith PM; Chitneni P; Bosman S; Bangsberg DR; Marrazzo JM; Smit JA; Matthews LT
Sex Transm Dis; 2024 Jun; 51(6):431-436. PubMed ID: 38372541
[TBL] [Abstract][Full Text] [Related]
20. Investigating point-of-care diagnostics for sexually transmitted infections and antimicrobial resistance in antenatal care in Zimbabwe (IPSAZ): protocol for a mixed-methods study.
Martin K; Dziva Chikwari C; Dauya E; Mackworth-Young CRS; Bath D; Tucker J; Simms V; Bandason T; Ndowa F; Katsidzira L; Mugurungi O; Machiha A; Marks M; Kranzer K; Ferrand R
BMJ Open; 2023 Apr; 13(4):e070889. PubMed ID: 37080628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
